JP2015107925A5 - - Google Patents

Download PDF

Info

Publication number
JP2015107925A5
JP2015107925A5 JP2013250978A JP2013250978A JP2015107925A5 JP 2015107925 A5 JP2015107925 A5 JP 2015107925A5 JP 2013250978 A JP2013250978 A JP 2013250978A JP 2013250978 A JP2013250978 A JP 2013250978A JP 2015107925 A5 JP2015107925 A5 JP 2015107925A5
Authority
JP
Japan
Prior art keywords
luteolin
extract
group
asparathus
linearis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013250978A
Other languages
English (en)
Japanese (ja)
Other versions
JP6211406B2 (ja
JP2015107925A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013250978A priority Critical patent/JP6211406B2/ja
Priority claimed from JP2013250978A external-priority patent/JP6211406B2/ja
Publication of JP2015107925A publication Critical patent/JP2015107925A/ja
Publication of JP2015107925A5 publication Critical patent/JP2015107925A5/ja
Application granted granted Critical
Publication of JP6211406B2 publication Critical patent/JP6211406B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013250978A 2013-12-04 2013-12-04 ムスカリン受容体活性化剤及び唾液分泌促進剤 Active JP6211406B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013250978A JP6211406B2 (ja) 2013-12-04 2013-12-04 ムスカリン受容体活性化剤及び唾液分泌促進剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013250978A JP6211406B2 (ja) 2013-12-04 2013-12-04 ムスカリン受容体活性化剤及び唾液分泌促進剤

Publications (3)

Publication Number Publication Date
JP2015107925A JP2015107925A (ja) 2015-06-11
JP2015107925A5 true JP2015107925A5 (sl) 2017-01-12
JP6211406B2 JP6211406B2 (ja) 2017-10-11

Family

ID=53438607

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013250978A Active JP6211406B2 (ja) 2013-12-04 2013-12-04 ムスカリン受容体活性化剤及び唾液分泌促進剤

Country Status (1)

Country Link
JP (1) JP6211406B2 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6841222B2 (ja) * 2015-06-04 2021-03-10 ライオン株式会社 唾液分泌促進剤、口腔乾燥抑制剤及び口腔内うるおい付与剤、及び組成物
JP2018080150A (ja) * 2016-11-18 2018-05-24 三栄源エフ・エフ・アイ株式会社 唾液分泌促進剤
WO2019208435A1 (ja) * 2018-04-26 2019-10-31 ライオン株式会社 外分泌促進剤
CN116251090A (zh) * 2022-12-02 2023-06-13 吉林大学 一种木犀草素缓解口干症状的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005085223A1 (ja) * 2004-03-04 2007-12-13 和夫 永井 骨疾患の予防及び/又は治療用組成物、その組成物を含有する機能性食品もしくは健康食品、並びにその組成物を有効成分とする医薬製剤
DK2512479T3 (en) * 2009-12-18 2016-06-06 Exodos Life Sciences Ltd Partnership Compositions for the treatment of peripheral vascular disease

Similar Documents

Publication Publication Date Title
EP2917180A4 (en) GPR40 RECEPTOR AGONIST, METHODS OF PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE SUBSTANCE
CA2894892A1 (en) Boronic acid derivatives and therapeutic uses thereof
RS56770B1 (sr) Čvrste forme 3-(5-amino-2-metil-4-okso-4h-hinazolin-3-il)-piperidin-2,6-diona i njihove farmaceutske smeše i upotrebe
ZA201200832B (en) Immunogenic composition comprising antigenic s. aureus proteins
JP2012520430A5 (sl)
BR112014010290A2 (pt) composição farmacêutica, métodos, composições e usos
UA102857C2 (en) Quinuclidine carbonate derivatives and use thereof
EA201590805A1 (ru) Композиция с немедленным и пролонгированным высвобождением
MX355831B (es) NOVEDOSOS HIDRATOS CRISTALINOS DE 1-(ß-D-GLUCOPIRANOSIL)-4-METIL-3 -[5-(4-FLUORO-FENIL)-2-TIENIL-METIL]-BENCENO.
HK1220965A1 (zh) 鹽、相關的晶體形式、其製備方法以及含有其的藥物組合物
WO2014203275A3 (en) An improved process for the preparation of apixaban and intermediates thereof
WO2010144477A3 (en) Sulfonylurea modulators of endothelin receptor
WO2011122872A3 (ko) 쿠메스트롤 또는 쿠메스트롤을 포함하는 콩 추출물 포함 조성물
EP2468771A4 (en) PHARMACEUTICAL COMPOSITION WITH AN ANTIBODY TO HB-EGF AS AN ACTIVE SUBSTANCE
JP2015107925A5 (sl)
JP2014500291A5 (sl)
EP3564224A3 (en) Crystalline form of vortioxetine hydrobromide as antidepressant drug
WO2011091410A8 (en) Trpv4 antagonists
WO2012029074A3 (en) Pharmaceutical compositions of linezolid
EP2871187A4 (en) NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT
WO2012125525A3 (en) Equine rhinitis vaccine
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
WO2012093973A3 (en) Compositions in the form of tablets comprising acarbose
JP2014101346A5 (sl)
JP2013079218A5 (sl)